Clinical Trial Update: Dacarbazine for Metastatic Soft Tissue and Bone Sarcoma [Phase 2]

View source ↗

Summary

Phase 2 trial of dacarbazine in metastatic soft tissue and bone sarcoma has completed, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Sarcoma
• Soft Tissue Sarcoma

Drugs mentioned

• Dacarbazine (dacarbazine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Sarcoma | Phase 2 | Status: COMPLETED | Results posted: 2017-02-13